Search

everythinglearnresearchcommunity

for

Search:↓

Nutraceuticals that promote hair growth do not reduce tamoxifen's effectiveness in breast cancer treatment.

Cyproterone acetate and ethinylestradiol effectively reduce hirsutism and acne in women.

ODAC members faced intense pressure but prioritized scientific evidence in drug approval decisions.

Liposomes show promise in cancer treatment by delivering drugs with less toxicity and improved effectiveness.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

Chemotherapy affects blood vessels in hair follicles, not stem cells, allowing hair regrowth.

Deuruxolitinib effectively treats alopecia areata but may cause manageable side effects.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

Tyrosine kinase inhibitors for endocrine tumors often cause skin issues, requiring early management and treatment adjustments.

Skin reactions from cancer treatments might predict how well the treatments work.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

Photodynamic therapy improved skin issues from sorafenib when other treatments failed.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Adding celecoxib to chemotherapy improves survival and quality of life for gastric cancer patients with positive COX-2.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

EGFR-TKIs can cause unexpected skin, nail, and hair issues.

M50054 may help treat hepatitis and hair loss from chemotherapy.

Tridax procumbens extracts may help treat cancer due to their strong anticancer and antioxidant properties.

Prevent persistent hair loss after chemotherapy with scalp cooling and early minoxidil use.

Including androgens in hormone therapy may lower breast cancer risk.

The combination therapy was effective and well-tolerated, especially in young patients.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Activated ras can protect kidney cells from a certain substance that causes cell death.

The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.

Low-dose oral minoxidil combined with topical minoxidil improves hair density in breast cancer patients but may cause excess hair growth.

Dutasteride may help treat prostate cancer by causing cancer cells to shrink and die.

Non-daily Dutasteride is more cost-effective and has lower cancer incidence than daily treatment.

Deucravacitinib did not significantly improve hair regrowth in alopecia areata patients.